{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T06:18:52Z","timestamp":1792045132985,"version":"4.4.0"},"reference-count":58,"publisher":"American Society of Hematology","issue":"9","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2005,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The pleiotropic cytokine tumor necrosis factor-\u03b1 (TNF-\u03b1) and thrombin lead to increased endothelial permeability in sepsis. Numerous studies demonstrated the significance of intracellular cyclic nucleotides for the maintenance of endothelial barrier function. Actions of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) are terminated by distinct cyclic nucleotide phosphodiesterases (PDEs). We hypothesized that TNF-\u03b1 could regulate PDE activity in endothelial cells, thereby impairing endothelial barrier function. In cultured human umbilical vein endothelial cells (HUVECs), we found a dramatic increase of PDE2 activity following TNF-\u03b1 stimulation, while PDE3 and PDE4 activities remained unchanged. Significant PDE activities other than PDE2, PDE3, and PDE4 were not detected. TNF-\u03b1 increased PDE2 expression in a p38 mitogen-activated protein kinase (MAPK)\u2013dependent manner. Endothelial barrier function was investigated in HUVECs and in isolated mice lungs. Selective PDE2 up-regulation sensitized HUVECs toward the permeability-increasing agent thrombin. In isolated mice lungs, we demonstrated that PDE2 inhibition was effective in preventing thrombin-induced lung edema, as shown with a reduction in both lung wet-to-dry ratio and albumin flux from the vascular to bronchoalveolar compartment. Our findings suggest that TNF-\u03b1\u2013mediated up-regulation of PDE2 may destabilize endothelial barrier function in sepsis. Inhibition of PDE2 is therefore of potential therapeutic interest in sepsis and acute respiratory distress syndrome (ARDS).<\/jats:p>","DOI":"10.1182\/blood-2004-07-2729","type":"journal-article","created":{"date-parts":[[2005,1,14]],"date-time":"2005-01-14T01:29:44Z","timestamp":1105666184000},"page":"3569-3576","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":124,"title":["Tumor necrosis factor-\u03b1\u2013dependent expression of phosphodiesterase 2: role in endothelial hyperpermeability"],"prefix":"10.1182","volume":"105","author":[{"given":"Joachim","family":"Seybold","sequence":"first","affiliation":[{"name":"From the Charite\u0301 Universita\u0308tsmedizin Berlin, Humboldt-University, Department of Internal Medicine\/Infectious Diseases, Berlin, Germany; and Altana Pharma, Konstanz, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Thomas","sequence":"additional","affiliation":[{"name":"From the Charite\u0301 Universita\u0308tsmedizin Berlin, Humboldt-University, Department of Internal Medicine\/Infectious Diseases, Berlin, Germany; and Altana Pharma, Konstanz, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Witzenrath","sequence":"additional","affiliation":[{"name":"From the Charite\u0301 Universita\u0308tsmedizin Berlin, Humboldt-University, Department of Internal Medicine\/Infectious Diseases, Berlin, Germany; and Altana Pharma, Konstanz, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u0327engu\u0308l","family":"Boral","sequence":"additional","affiliation":[{"name":"From the Charite\u0301 Universita\u0308tsmedizin Berlin, Humboldt-University, Department of Internal Medicine\/Infectious Diseases, Berlin, Germany; and Altana Pharma, Konstanz, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas C.","family":"Hocke","sequence":"additional","affiliation":[{"name":"From the Charite\u0301 Universita\u0308tsmedizin Berlin, Humboldt-University, Department of Internal Medicine\/Infectious Diseases, Berlin, Germany; and Altana Pharma, Konstanz, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Bu\u0308rger","sequence":"additional","affiliation":[{"name":"From the Charite\u0301 Universita\u0308tsmedizin Berlin, Humboldt-University, Department of Internal Medicine\/Infectious Diseases, Berlin, Germany; and Altana Pharma, Konstanz, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armin","family":"Hatzelmann","sequence":"additional","affiliation":[{"name":"From the Charite\u0301 Universita\u0308tsmedizin Berlin, Humboldt-University, Department of Internal Medicine\/Infectious Diseases, Berlin, Germany; and Altana Pharma, Konstanz, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermann","family":"Tenor","sequence":"additional","affiliation":[{"name":"From the Charite\u0301 Universita\u0308tsmedizin Berlin, Humboldt-University, Department of Internal Medicine\/Infectious Diseases, Berlin, Germany; and Altana Pharma, Konstanz, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Schudt","sequence":"additional","affiliation":[{"name":"From the Charite\u0301 Universita\u0308tsmedizin Berlin, Humboldt-University, Department of Internal Medicine\/Infectious Diseases, Berlin, Germany; and Altana Pharma, Konstanz, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Kru\u0308ll","sequence":"additional","affiliation":[{"name":"From the Charite\u0301 Universita\u0308tsmedizin Berlin, Humboldt-University, Department of Internal Medicine\/Infectious Diseases, Berlin, Germany; and Altana Pharma, Konstanz, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartwig","family":"Schu\u0308tte","sequence":"additional","affiliation":[{"name":"From the Charite\u0301 Universita\u0308tsmedizin Berlin, Humboldt-University, Department of Internal Medicine\/Infectious Diseases, Berlin, Germany; and Altana Pharma, Konstanz, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Hippenstiel","sequence":"additional","affiliation":[{"name":"From the Charite\u0301 Universita\u0308tsmedizin Berlin, Humboldt-University, Department of Internal Medicine\/Infectious Diseases, Berlin, Germany; and Altana Pharma, Konstanz, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Suttorp","sequence":"additional","affiliation":[{"name":"From the Charite\u0301 Universita\u0308tsmedizin Berlin, Humboldt-University, Department of Internal Medicine\/Infectious Diseases, Berlin, Germany; and Altana Pharma, Konstanz, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021223002554700_REF1","doi-asserted-by":"crossref","unstructured":"Aird WC. The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood. 2003;101: 3765-3777.","DOI":"10.1182\/blood-2002-06-1887"},{"key":"2020021223002554700_REF2","doi-asserted-by":"crossref","unstructured":"Ferro T, Neumann P, Gertzberg N, Clements R, Johnson A. Protein kinase C-alpha mediates endothelial barrier dysfunction induced by TNF-alpha. Am J Physiol Lung Cell Mol Physiol. 2000;278: L1107-L1117.","DOI":"10.1152\/ajplung.2000.278.6.L1107"},{"key":"2020021223002554700_REF3","doi-asserted-by":"crossref","unstructured":"Johnson J, Meyrick B, Jesmok G, Brigham KL. Human recombinant tumor necrosis factor alpha infusion mimics endotoxemia in awake sheep. J Appl Physiol. 1989;66: 1448-1454.","DOI":"10.1152\/jappl.1989.66.3.1448"},{"key":"2020021223002554700_REF4","doi-asserted-by":"crossref","unstructured":"Rangel-Frausto MS, Pittet D, Costigan M, et al. The natural history of the systemic inflammatory response syndrome (SIRS): a prospective study. JAMA. 1995;273: 117-123.","DOI":"10.1001\/jama.1995.03520260039030"},{"key":"2020021223002554700_REF5","doi-asserted-by":"crossref","unstructured":"Lum H, Malik AB. Regulation of vascular endothelial barrier function. Am J Physiol. 1994;267: L223-L241.","DOI":"10.1152\/ajplung.1994.267.3.L223"},{"key":"2020021223002554700_REF6","doi-asserted-by":"crossref","unstructured":"Tiruppathi C, Naqvi T, Sandoval R, Mehta D, Malik AB. Synergistic effects of tumor necrosis factor-alpha and thrombin in increasing endothelial permeability. Am J Physiol Lung Cell Mol Physiol. 2001;281: L958-L968.","DOI":"10.1152\/ajplung.2001.281.4.L958"},{"key":"2020021223002554700_REF7","doi-asserted-by":"crossref","unstructured":"Kataoka H, Hamilton JR, McKemy DD, et al. Protease-activated receptors 1 and 4 mediate thrombin signaling in endothelial cells. Blood. 2003;102: 3224-3231.","DOI":"10.1182\/blood-2003-04-1130"},{"key":"2020021223002554700_REF8","doi-asserted-by":"crossref","unstructured":"Coughlin SR. Thrombin signalling and protease-activated receptors. Nature. 2000;407: 258-264.","DOI":"10.1038\/35025229"},{"key":"2020021223002554700_REF9","doi-asserted-by":"crossref","unstructured":"Aggarwal BB. Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol. 2003;3: 745-756.","DOI":"10.1038\/nri1184"},{"key":"2020021223002554700_REF10","doi-asserted-by":"crossref","unstructured":"Hippenstiel S, Witzenrath M, Schmeck B, et al. Adrenomedullin reduces endothelial hyperpermeability. Circ Res. 2002;91: 618-625.","DOI":"10.1161\/01.RES.0000036603.61868.F9"},{"key":"2020021223002554700_REF11","doi-asserted-by":"crossref","unstructured":"Garcia JG, Verin AD, Schaphorst KL. Regulation of thrombin-mediated endothelial cell contraction and permeability. Semin Thromb Hemost. 1996;22: 309-315.","DOI":"10.1055\/s-2007-999025"},{"key":"2020021223002554700_REF12","doi-asserted-by":"crossref","unstructured":"Petrache I, Verin AD, Crow MT, et al. Differential effect of MLC kinase in TNF-alpha-induced endothelial cell apoptosis and barrier dysfunction. Am J Physiol Lung Cell Mol Physiol. 2001;280: L1168-L1178.","DOI":"10.1152\/ajplung.2001.280.6.L1168"},{"key":"2020021223002554700_REF13","doi-asserted-by":"crossref","unstructured":"Suttorp N, Weber U, Welsch T, Schudt C. Role of phosphodiesterases in the regulation of endothelial permeability in vitro. J Clin Invest. 1993;91: 1421-1428.","DOI":"10.1172\/JCI116346"},{"key":"2020021223002554700_REF14","unstructured":"Suttorp N, Ehreiser P, Hippenstiel S, et al. Hyperpermeability of pulmonary endothelial monolayer: protective role of phosphodiesterase isoenzymes 3 and 4. Lung. 1996;174: 181-194."},{"key":"2020021223002554700_REF15","doi-asserted-by":"crossref","unstructured":"Suttorp N, Hippenstiel S, Fuhrmann M, Krull M, Podzuweit T. Role of nitric oxide and phosphodiesterase isoenzyme II for reduction of endothelial hyperpermeability. Am J Physiol. 1996;270: C778-C785.","DOI":"10.1152\/ajpcell.1996.270.3.C778"},{"key":"2020021223002554700_REF16","doi-asserted-by":"crossref","unstructured":"Lum H, Jaffe HA, Schulz IT, et al. Expression of PKA inhibitor (PKI) gene abolishes cAMP-mediated protection to endothelial barrier dysfunction. Am J Physiol. 1999;277: C580-C588.","DOI":"10.1152\/ajpcell.1999.277.3.C580"},{"key":"2020021223002554700_REF17","unstructured":"Beavo JA, Conti M, Heaslip RJ. Multiple cyclic nucleotide phosphodiesterases. Mol Pharmacol. 1994;46: 399-405."},{"key":"2020021223002554700_REF18","doi-asserted-by":"crossref","unstructured":"Soderling SH, Beavo JA. Regulation of cAMP and cGMP signaling: new phosphodiesterases and new functions. Curr Opin Cell Biol. 2000;12: 174-179.","DOI":"10.1016\/S0955-0674(99)00073-3"},{"key":"2020021223002554700_REF19","doi-asserted-by":"crossref","unstructured":"Beavo JA. Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiol Rev. 1995;75: 725-748.","DOI":"10.1152\/physrev.1995.75.4.725"},{"key":"2020021223002554700_REF20","doi-asserted-by":"crossref","unstructured":"Conti M, Nemoz G, Sette C, Vicini E. Recent progress in understanding the hormonal regulation of phosphodiesterases. Endocr Rev. 1995;16: 370-389.","DOI":"10.1210\/edrv-16-3-370"},{"key":"2020021223002554700_REF21","doi-asserted-by":"crossref","unstructured":"Martinez SE, Wu AY, Glavas NA, et al. The two GAF domains in phosphodiesterase 2A have distinct roles in dimerization and in cGMP binding. Proc Natl Acad Sci U S A. 2002;99: 13260-13265.","DOI":"10.1073\/pnas.192374899"},{"key":"2020021223002554700_REF22","doi-asserted-by":"crossref","unstructured":"Rosman GJ, Martins TJ, Sonnenburg WK, et al. Isolation and characterization of human cDNAs encoding a cGMP-stimulated 3',5'-cyclic nucleotide phosphodiesterase. Gene. 1997;191: 89-95.","DOI":"10.1016\/S0378-1119(97)00046-2"},{"key":"2020021223002554700_REF23","doi-asserted-by":"crossref","unstructured":"Rivet-Bastide M, Vandecasteele G, Hatem S, et al. cGMP-stimulated cyclic nucleotide phosphodiesterase regulates the basal calcium current in human atrial myocytes. J Clin Invest. 1997;99: 2710-2718.","DOI":"10.1172\/JCI119460"},{"key":"2020021223002554700_REF24","doi-asserted-by":"crossref","unstructured":"Sadhu K, Hensley K, Florio VA, Wolda SL. Differential expression of the cyclic GMP-stimulated phosphodiesterase PDE2A in human venous and capillary endothelial cells. J Histochem Cytochem. 1999;47: 895-906.","DOI":"10.1177\/002215549904700707"},{"key":"2020021223002554700_REF25","doi-asserted-by":"crossref","unstructured":"Seeger W, Hansen T, Rossig R, et al. Hydrogen peroxide-induced increase in lung endothelial and epithelial permeability\u2014effect of adenylate cyclase stimulation and phosphodiesterase inhibition. Microvasc Res. 1995;50: 1-17.","DOI":"10.1006\/mvre.1995.1033"},{"key":"2020021223002554700_REF26","doi-asserted-by":"crossref","unstructured":"Hippenstiel S, Krull M, Ikemann A, et al. VEGF induces hyperpermeability by a direct action on endothelial cells. Am J Physiol. 1998;274: L678-L684.","DOI":"10.1152\/ajplung.1998.274.5.L678"},{"key":"2020021223002554700_REF27","doi-asserted-by":"crossref","unstructured":"McAllister-Lucas LM, Sonnenburg WK, Kadlecek A, et al. The structure of a bovine lung cGMP-binding, cGMP-specific phosphodiesterase deduced from a cDNA clone. J Biol Chem. 1993;268: 22863-22873.","DOI":"10.1016\/S0021-9258(18)41607-9"},{"key":"2020021223002554700_REF28","doi-asserted-by":"crossref","unstructured":"Seybold J, Newton R, Wright L, et al. Induction of phosphodiesterases 3B, 4A4, 4D1, 4D2, and 4D3 in Jurkat T-cells and in human peripheral blood T-lymphocytes by 8-bromo-cAMP and Gs-coupled receptor agonists: potential role in beta2-adrenoreceptor desensitization. J Biol Chem. 1998;273: 20575-20588.","DOI":"10.1074\/jbc.273.32.20575"},{"key":"2020021223002554700_REF29","doi-asserted-by":"crossref","unstructured":"Thompson WJ, Brooker G, Appleman MM. Assay of cyclic nucleotide phosphodiesterases with radioactive substrates. Methods Enzymol. 1974;38: 205-212.","DOI":"10.1016\/0076-6879(74)38033-0"},{"key":"2020021223002554700_REF30","doi-asserted-by":"crossref","unstructured":"Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72: 248-254.","DOI":"10.1016\/0003-2697(76)90527-3"},{"key":"2020021223002554700_REF31","doi-asserted-by":"crossref","unstructured":"Ludwig S, Hoffmeyer A, Goebeler M, et al. The stress inducer arsenite activates mitogen-activated protein kinases extracellular signal-regulated kinases 1 and 2 via a MAPK kinase 6\/p38-dependent pathway. J Biol Chem. 1998;273: 1917-1922.","DOI":"10.1074\/jbc.273.4.1917"},{"key":"2020021223002554700_REF32","doi-asserted-by":"crossref","unstructured":"Seybold J, Suttorp N. Pulmonary artery endothelial cells. In: Donnely LE, Rogers DF, eds. Human Airway Inflammation. Totawa, NJ: Humana Press; 2001: 147-154.","DOI":"10.1385\/1-59259-151-5:147"},{"key":"2020021223002554700_REF33","doi-asserted-by":"crossref","unstructured":"Suttorp N, Polley M, Seybold J, et al. Adenosine diphosphate-ribosylation of G-actin by botulinum C2 toxin increases endothelial permeability in vitro. J Clin Invest. 1991;87: 1575-1584.","DOI":"10.1172\/JCI115171"},{"key":"2020021223002554700_REF34","doi-asserted-by":"crossref","unstructured":"von Bethmann AN, Brasch F, Nusing R, et al. Hyperventilation induces release of cytokines from perfused mouse lung. Am J Respir Crit Care Med. 1998;157: 263-272.","DOI":"10.1164\/ajrccm.157.1.9608052"},{"key":"2020021223002554700_REF35","doi-asserted-by":"crossref","unstructured":"Folz RJ, Abushamaa AM, Suliman HB. Extracellular superoxide dismutase in the airways of transgenic mice reduces inflammation and attenuates lung toxicity following hyperoxia. J Clin Invest. 1999;103: 1055-1066.","DOI":"10.1172\/JCI3816"},{"key":"2020021223002554700_REF36","doi-asserted-by":"crossref","unstructured":"Matute-Bello G, Frevert CW, Liles WC, et al. Fas\/Fas ligand system mediates epithelial injury, but not pulmonary host defenses, in response to inhaled bacteria. Infect Immun. 2001;69: 5768-5776.","DOI":"10.1128\/IAI.69.9.5768-5776.2001"},{"key":"2020021223002554700_REF37","doi-asserted-by":"crossref","unstructured":"Nwariaku FE, Rothenbach P, Liu Z, Zhu X, Turnage RH, Terada LS. Rho inhibition decreases TNF-induced endothelial MAPK activation and monolayer permeability. J Appl Physiol. 2003;95: 1889-1995.","DOI":"10.1152\/japplphysiol.00225.2003"},{"key":"2020021223002554700_","doi-asserted-by":"crossref","unstructured":"Gertzberg N, Neumann P, Rizzo V, Johnson A. NAD(P)H-oxidase mediates the endothelial barrier dysfunction induced by TNF-{alpha}. Am J Physiol Lung Cell Mol Physiol. 2004;286: L37-L48.","DOI":"10.1152\/ajplung.00116.2003"},{"key":"2020021223002554700_","doi-asserted-by":"crossref","unstructured":"Wojciak-Stothard B, Ridley AJ. Rho GTPases and the regulation of endothelial permeability. Vascul Pharmacol. 2002;39: 187-199.","DOI":"10.1016\/S1537-1891(03)00008-9"},{"key":"2020021223002554700_","doi-asserted-by":"crossref","unstructured":"Petrache I, Birukova A, Ramirez SI, Garcia JG, Verin AD. The role of the microtubules in tumor necrosis factor-alpha-induced endothelial cell permeability. Am J Respir Cell Mol Biol. 2003;28: 574-581.","DOI":"10.1165\/rcmb.2002-0075OC"},{"key":"2020021223002554700_REF41","doi-asserted-by":"crossref","unstructured":"Friedl J, Puhlmann M, Bartlett DL, et al. Induction of permeability across endothelial cell monolayers by tumor necrosis factor (TNF) occurs via a tissue factor-dependent mechanism: relationship between the procoagulant and permeability effects of TNF. Blood. 2002;100: 1334-1339.","DOI":"10.1182\/blood.V100.4.1334.h81602001334_1334_1339"},{"key":"2020021223002554700_REF42","doi-asserted-by":"crossref","unstructured":"Lum H, Andersen TT, Fenton JW, Malik AB. Thrombin receptor activation peptide induces pulmonary vasoconstriction. Am J Physiol. 1994;266: C448-C454.","DOI":"10.1152\/ajpcell.1994.266.2.C448"},{"key":"2020021223002554700_REF43","doi-asserted-by":"crossref","unstructured":"Schulman CI, Wright JK, Nwariaku F, Sarosi G, Turnage RH. The effect of tumor necrosis factor-alpha on microvascular permeability in an isolated, perfused lung. Shock. 2002;18: 75-81.","DOI":"10.1097\/00024382-200207000-00014"},{"key":"2020021223002554700_REF44","doi-asserted-by":"crossref","unstructured":"Bonsignore MR, Valenti A, Spatafora M. Tumor necrosis factor-alpha does not cause lung edema in rabbits. J Appl Physiol. 1992;73: 173-178.","DOI":"10.1152\/jappl.1992.73.1.173"},{"key":"2020021223002554700_REF45","doi-asserted-by":"crossref","unstructured":"Lo SK, Everitt J, Gu J, Malik AB. Tumor necrosis factor mediates experimental pulmonary edema by ICAM-1 and CD18-dependent mechanisms. J Clin Invest. 1992;89: 981-988.","DOI":"10.1172\/JCI115681"},{"key":"2020021223002554700_REF46","doi-asserted-by":"crossref","unstructured":"Ishii Y, Partridge CA, Del Vecchio PJ, Malik AB. Tumor necrosis factor-alpha-mediated decrease in glutathione increases the sensitivity of pulmonary vascular endothelial cells to H2O2. J Clin Invest. 1992;89: 794-802.","DOI":"10.1172\/JCI115658"},{"key":"2020021223002554700_REF47","doi-asserted-by":"crossref","unstructured":"Goldblum SE, Sun WL. Tumor necrosis factor-alpha augments pulmonary arterial transendothelial albumin flux in vitro. Am J Physiol. 1990;258: L57-L67.","DOI":"10.1152\/ajplung.1990.258.2.L57"},{"key":"2020021223002554700_REF48","doi-asserted-by":"crossref","unstructured":"Takata M, Filippov G, Liu H, et al. Cytokines decrease sGC in pulmonary artery smooth muscle cells via NO-dependent and NO-independent mechanisms. Am J Physiol Lung Cell Mol Physiol. 2001;280: L272-L278.","DOI":"10.1152\/ajplung.2001.280.2.L272"},{"key":"2020021223002554700_REF49","doi-asserted-by":"crossref","unstructured":"Koga S, Morris S, Ogawa S, et al. TNF modulates endothelial properties by decreasing cAMP. Am J Physiol. 1995;268: C1104-C1113.","DOI":"10.1152\/ajpcell.1995.268.5.C1104"},{"key":"2020021223002554700_REF50","doi-asserted-by":"crossref","unstructured":"Nieuw Amerongen GP, van Hinsbergh VW. Targets for pharmacological intervention of endothelial hyperpermeability and barrier function. Vascul Pharmacol. 2002;39: 257-272.","DOI":"10.1016\/S1537-1891(03)00014-4"},{"key":"2020021223002554700_REF51","doi-asserted-by":"crossref","unstructured":"Goebeler M, Kilian K, Gillitzer R, et al. The MKK6\/p38 stress kinase cascade is critical for tumor necrosis factor-alpha-induced expression of monocyte-chemoattractant protein-1 in endothelial cells. Blood. 1999;93: 857-865.","DOI":"10.1182\/blood.V93.3.857"},{"key":"2020021223002554700_REF52","doi-asserted-by":"crossref","unstructured":"Hoefen RJ, Berk BC. The role of MAP kinases in endothelial activation. Vascul Pharmacol. 2002;38: 271-273.","DOI":"10.1016\/S1537-1891(02)00251-3"},{"key":"2020021223002554700_REF53","doi-asserted-by":"crossref","unstructured":"Madge LA, Pober JS. TNF signaling in vascular endothelial cells. Exp Mol Pathol. 2001;70: 317-325.","DOI":"10.1006\/exmp.2001.2368"},{"key":"2020021223002554700_REF54","doi-asserted-by":"crossref","unstructured":"Draijer R, Atsma DE, van der LA, van Hinsbergh VW. cGMP and nitric oxide modulate thrombin-induced endothelial permeability: regulation via different pathways in human aortic and umbilical vein endothelial cells. Circ Res. 1995;76: 199-208.","DOI":"10.1161\/01.RES.76.2.199"},{"key":"2020021223002554700_REF55","doi-asserted-by":"crossref","unstructured":"Suttorp N, Fuhrmann M, Tannert-Otto S, Grimminger F, Bhadki S. Pore-forming bacterial toxins potently induce release of nitric oxide in porcine endothelial cells. J Exp Med. 1993;178: 337-341.","DOI":"10.1084\/jem.178.1.337"},{"key":"2020021223002554700_REF56","doi-asserted-by":"crossref","unstructured":"Miotla JM, Teixeira MM, Hellewell PG. Suppression of acute lung injury in mice by an inhibitor of phosphodiesterase type 4. Am J Respir Cell Mol Biol. 1998;18: 411-420.","DOI":"10.1165\/ajrcmb.18.3.2913"},{"key":"2020021223002554700_REF57","doi-asserted-by":"crossref","unstructured":"Lejeune FJ. Clinical use of TNF revisited: improving penetration of anti-cancer agents by increasing vascular permeability. J Clin Invest. 2002;110: 433-435.","DOI":"10.1172\/JCI0216493"},{"key":"2020021223002554700_REF58","doi-asserted-by":"crossref","unstructured":"Lejeune FJ, Ruegg C, Lienard D. Clinical applications of TNF-alpha in cancer. Curr Opin Immunol. 1998;10: 573-580.","DOI":"10.1016\/S0952-7915(98)80226-4"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/105\/9\/3569\/1710144\/zh800905003569.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/105\/9\/3569\/1710144\/zh800905003569.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,4]],"date-time":"2021-07-04T01:13:04Z","timestamp":1625361184000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/105\/9\/3569\/21288\/Tumor-necrosis-factor%CE%B1dependent-expression-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5,1]]},"references-count":58,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2005,5,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2004-07-2729","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,5,1]]}}}